Details:

Alternative Title:
Influenza Other Respir Viruses
Publisher's site:
http://dx.doi.org/10.1111/j.1750-2659.2011.00242.x
Personal Author:
Haaheim, Lars R. ; Katz, Jacqueline M.
Haaheim, Lars R. ; Katz, Jacqueline M. Less -
Description:
The emergence of a novel swine-origin pandemic influenza virus in 2009, together with the continuing circulation of highly pathogenic avian H5N1 viruses and the urgent global need to produce effective vaccines against such public health threats, has prompted a renewed interest in improving our understanding of the immune correlates of protection against influenza. As new influenza vaccine technologies, including non-HA based approaches and novel production platforms are developed and undergo clinical evaluation, it has become clear that existing immune correlates such as serum hemagglutination-inhibition antibodies may be unsuitable to estimate vaccine immunogenicity and protective efficacy of such vaccines. This International Society for Influenza and other Respiratory Virus Diseases (ISIRV) sponsored international meeting held in Miami, Florida USA on March 1-3, 2010, brought together scientists from industry, academia, and government agencies that develop and evaluate seasonal and pandemic influenza vaccines and scientists from regulatory authorities that approve them, to identify approaches to develop expanded immune correlates of protection to aid in vaccine licensure.
Subjects:
[+]
Biological Markers Drug Approval Humans Influenza, Human Influenza Vaccines Licensure Meeting Report
Source:
Influenza Other Respir Viruses. 5(4):288-295.
Pubmed ID:
21651740
Pubmed Central ID:
PMC4634548
Document Type:
Journal Article
Place as Subject:
Florida
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:ce6e1c8eed25c1aceb7ce0d7c6a17f434ebc3b0da874e6ca4898bf28e192a6b1
Download URL:
https://stacks.cdc.gov/view/cdc/36162/cdc_36162_DS1.pdf
File Type:

Supporting Files

• 	IRV-5-288.nxml	bin
  	license.txt	txt

More +